Yestar Healthcare Holdings Company Limited (02393)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Chan Chung Man15-Mar-1802-Nov-20COO, ED
29-Jan-1615-Mar-18ED
Chan To Keung01-Feb-1230-Oct-19ED
Dr. Hu Yiming31-May-23INEDFor the purpose of maintaining their objectivity and independence of the Board and the Group as both of them have joined the Company since its listing in 2013 and have consecutively served the Company for nine years.
Hartono James24-Aug-22Ch, NED
01-Feb-1224-Aug-22Ch, CEOHe would like to devote more time and dedication on strategic and financial planning of the Group. Redesignated from executive director to non-executive director.
24-Aug-22EDHe would like to devote more time and dedication on strategic and financial planning of the Group. Redesignated from executive director to non-executive director.
Heng Yinmei01-Feb-1229-Jan-16ED
Hu Yi Ming18-Sep-1331-May-23INED
Huang Deyin02-Jul-13INED
Karsono Tirtamarta18-Sep-1328-May-21INED
Koeswondo Michael David31-May-23INED
Koo Timmie Cheuk On01-Apr-1208-May-15CoSec
Li Bin18-Jun-2131-Dec-21ED
Liang Junxiong31-Dec-2128-Mar-24EDDue to his other business commitments and plans for his further career as well as business development
Liao Changxiang27-Jun-25MbNC
24-Aug-2202-Apr-25CEOResignation following the implementation and execution of the succession plan for the role of chief executive officer.
02-Nov-2024-Aug-22ED
Ng Ivan Chit Sing08-May-1531-Dec-21CoSec
Ngai Michael Tsz Hin31-Dec-21CoSec
Qiao Jinrong15-Oct-24FD
Sutikno Liky18-Sep-1331-May-23INEDFor the purpose of maintaining their objectivity and independence of the Board and the Group as both of them have joined the Company since its listing in 2013 and have consecutively served the Company for nine years.
Wang Hong01-Feb-1215-Oct-24FD
15-Oct-24EDTo devote more time to her family.
Wang Ying22-Feb-1324-Dec-21ED
Zeng Jinsong28-May-21INED
02-Jul-13INED
Zhang Qi01-Feb-1229-Jan-16ED
Zhao Ziwei31-May-23INED
27-Jun-25MbNCCeased to be a member of the Nomination Committee as part of a change in the composition of the Board Committee.